Artiva Biotherapeutics Appoints New CFO and COO, Prepares for Growth Phase
Artiva Biotherapeutics, Inc., a clinical-stage company focused on delivering off-the-shelf NK cell-based therapies, appointed Neha Krishnamohan as CFO and EVP, Corporate Development, and promoted Jennifer Bush to COO. Krishnamohan’s financial and strategic expertise, along with Bush’s contributions since 2020, are…
2024 Oncology Collaboration & Licensing Report: 3685 Deals Analyzed – ResearchAndMarkets.com
The “Oncology Collaboration and Licensing Deals 2019-2024” report, recently incorporated into ResearchAndMarkets.com’s offerings, presents an in-depth examination of 3685 oncology deals inked by leading biopharmaceutical companies worldwide between 2019 and 2024. This comprehensive report equips readers with unparalleled access to…
n-Lorem Foundation Teams Up with Hongene Biotech for Personalized ASO Medicines
The n-Lorem Foundation, a nonprofit organization dedicated to providing support and solutions for individuals afflicted with nano-rare diseases, has recently forged a significant partnership with Hongene Biotech Corporation. This collaboration aims to bolster n-Lorem’s ongoing mission of developing and delivering…
UW Medicine AIMS Center & Concert Health Expand Telepsychiatry Care
“Concert Health and AIMS Center Join Forces to Expand Telepsychiatry Care” Concert Health, a leading Collaborative Care platform, and the AIMS Center at the University of Washington Department of Psychiatry and Behavioral Sciences have announced a three-year project to enhance…
Incyte Acquires Escient Pharma’s Oral MRGPR Antagonists Pipeline
Incyte (Nasdaq:INCY) has entered a definitive agreement to acquire Escient Pharmaceuticals, a clinical-stage company focused on developing novel small molecule therapeutics for systemic immune and neuro-immune disorders. This acquisition includes EP262, a first-in-class, potent, highly selective, once-daily small molecule antagonist…
European Commission Approves Tislelizumab for Lung Cancer
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a leading oncology firm, revealed today that the European Commission (EC) has granted approval for tislelizumab as a treatment for non-small cell lung cancer (NSCLC) in three indications, encompassing both first- and…
KKR, Impilo, Management Partner in Immedica Pharma
KKR, a prominent global investment firm, along with Impilo, a Nordic healthcare investment firm, has agreed to acquire Immedica Pharma, a Swedish-based pharmaceutical company specializing in rare diseases and specialty care products. As part of the deal, Impilo will reinvest…
FDA Approves ANKTIVA® for BCG-Unresponsive Bladder Cancer
ImmunityBio, Inc. (NASDAQ: IBRX), a leader in immunotherapy, has just received FDA approval for ANKTIVA (N-803, or nogapendekin alfa inbakicept-pmln) in combination with Bacillus Calmette-Guérin (BCG). This approval marks a significant advancement in the treatment of patients with BCG-unresponsive non-muscle…
Institutions Enroll First Alzheimer’s Patients in CARE PMR Study
Hyperfine, Inc. (Nasdaq: HYPR), known for its groundbreaking health technology, has initiated the CARE PMR observational study, enrolling the first patients. The study aims to evaluate the clinical utility and workflow benefits of its FDA-cleared portable magnetic resonance (MR) brain…
Cera Expands Advisory Board with New Members
Cera, the acclaimed digital home healthcare provider, has appointed four new members to its Advisory Board: Lord Wood of Anfield, Hilary Evans, Benjamin Wegg-Prosser, and Samantha Jones. Cera, the esteemed digital home healthcare provider, has augmented its Advisory Board with…
2024 Global Infectious Disease Diagnostics Report by ResearchAndMarkets.com
ResearchAndMarkets.com now offers the “Global Infectious Disease In vitro Diagnostics Market (2024 Edition)” report. This comprehensive analysis covers various aspects including technology (such as Immunoassay, Molecular Diagnostics, Microbiology, and Other Technologies), product type, end user, region, and country, providing valuable…
CharmHealth Launches 2024 Innovation Challenge for Healthcare Providers
CharmHealth, a prominent provider of healthcare technology solutions, has officially launched its 2024 Innovation Challenge. This annual event aims to uncover fresh concepts that can revolutionize healthcare and its associated systems and procedures. The Innovation Challenge offers a platform for…